Status:
UNKNOWN
Lyon Granulomatous Hepatitis Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Patient Diagnosed or Treated for Granulomatous Hepatitis Followed in the Internal Medicine (and or) Hepato-gastroenterology Departments
Eligibility:
All Genders
18+ years
Brief Summary
Granulomatous hepatitis are histopathologically defined by the presence of epithelioid and gigantocellular granulomas within the hepatic parenchyma. Hepatic granulomas are observed in 2 to 15% of live...
Eligibility Criteria
Inclusion
- Diagnosis of granulomatous hepatitis
- Patient followed in the internal medicine and / or Hepato-gastroenterology departments (Croix-Rousse Hospital, Edouard-Herriot Hospital, Lyon Sud Hospital Center)
- Collection of non-opposition
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04459897
Start Date
January 1 2019
End Date
January 1 2023
Last Update
July 7 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
: Hôpital de la Croix Rousse / GHN / service de médecine interne
Lyon, France, 69004
2
Hôpital Edouard Herriot / service de médecine interne
Lyon, France, 69008
3
Hôpital Lyon Sud / service de médecine interne
Pierre-Bénite, France, 69495